ToolGen

Beta

KRX Filings & Disclosures 2026

Risk Factors

• • No specific quantified foreign exchange risk or sensitivity disclosed
• • No new derivative trades, debt covenants, or regulatory risks explicitly added for FY2025

Management Discussion & Analysis

• • Revenue KRW 1.31B (+46.63% YoY), operating loss KRW 23.29B (-6.86%), net loss KRW 36.76B (-689.94%)
• • License income from gene-editing platform patents drove 80.5% of KRW 1.31B total revenue, reflecting patent monetization strategy

Business Overview

• • 2025 total revenue KRW 1,306B, 80.5% from patent licensing related to CRISPR gene editing platform
• • Introduced in 2025: Styx-T Platform next-gen CAR-T therapy and GEB-200 treatment for cardiovascular disease with CRISPR-Cas9 LNP delivery

What are the latest ToolGen DART filings in 2026?

ToolGen (KRX code 199800) has filed an annual report on March 19, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did ToolGen file its most recent annual report?

ToolGen filed its most recent annual report on March 19, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is ToolGen's KRX stock code?

ToolGen's KRX stock code is 199800. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 199800 to look up all ToolGen disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does ToolGen file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for ToolGen.

Where can I find ToolGen financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from ToolGen annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.